Skip to main content

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Patients with Moderately to Severely Active Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis Who Have an Inadequate R

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

Allakos Inc.

Start Date

April 7, 2020

End Date

November 29, 2023
 

Administered By

Medicine, Gastroenterology

Awarded By

Allakos Inc.

Start Date

April 7, 2020

End Date

November 29, 2023